Futura Medical (LON:FUM) Posts Earnings Results

Futura Medical (LON:FUM) issued its earnings results on Tuesday. The company reported GBX (0.20) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.

Futura Medical Trading Down 12.9%

LON FUM traded down GBX 0.05 on Wednesday, reaching GBX 0.33. 9,885,531 shares of the company were exchanged, compared to its average volume of 9,158,236. The business’s fifty day moving average price is GBX 0.42 and its 200 day moving average price is GBX 0.79. The stock has a market capitalization of £1.92 million, a P/E ratio of -0.12 and a beta of 0.02. Futura Medical has a fifty-two week low of GBX 0.24 and a fifty-two week high of GBX 10.45.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.